| anti-IgE | SEA | SWA | |||
---|---|---|---|---|---|---|
 | ng/ml | % | ng/ml | % | ng/ml | % |
pre-treatment (N = 32) | 24.3 (20.5;38.0) | 35.0 (22.6;51.8) | 32.8 (23.4;44.5) | 49.7 (26.9;61.6) | 31.5 (23.9;44.1) | 51.3 (21.5;66.9) |
1-day post-treatment (N = 29) | 16.5 (9.8, 26.0) | 14.5 (7.5;28.5) | 20.0 (9.0;36.0) | 19.1 (8.0;38.1) | 20.0 (9.8;31.0) | 17.1 (8.2;37.8) |
21-days post-treatment (N = 25) | 35.5 (22.8;51.0) | 20.5 (15.2;31.3) | 37.5 (29.0;63.3) | 25.7 (15.5;39.9) | 48.0 (37.0;68.3) | 33.2 (21.7;44.6) |